Deletion or inhibition of prolyl oligopeptidase blocks lithium-induced phosphorylation of GSK3b and Akt by activation of protein phosphatase 2A

dc.contributor.authorMyöhänen Timo T
dc.contributor.authorMertens Freke
dc.contributor.authorNorrbacka Susanna
dc.contributor.authorCui Hengjing
dc.contributor.organizationfi=biolääketieteen laitos|en=Institute of Biomedicine|
dc.contributor.organization-code2607100
dc.converis.publication-id66608141
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/66608141
dc.date.accessioned2022-10-28T13:51:56Z
dc.date.available2022-10-28T13:51:56Z
dc.description.abstractAlterations in prolyl oligopeptidase (PREP) activity have been connected, for example, with bipolar and major depressive disorder, and several studies have reported that lack or inhibition of PREP blocks the effects of lithium on inositol 1,4,5-triphosphate (IP3) levels. However, the impact of PREP modulation on other intracellular targets of lithium, such as glycogen synthase kinase 3 beta (GSK3b) or protein kinase B (Akt), has not been studied. We recently found that PREP regulates protein phosphatase 2A (PP2A), and because GSK3b and Akt are PP2A substrates, we studied if PREP-related lithium insensitivity is dependent on PP2A. To assess this, HEK-293 and SH-SY5Y cells with PREP deletion or PREP inhibition (KYP-2047) were exposed to lithium, and thereafter, the phosphorylation levels of GSK3b and Akt were measured by Western blot. As expected, PREP deletion and inhibition blocked the lithium-induced phosphorylation on GSK3b and Akt in both cell lines. When lithium exposure was combined with okadaic acid, a PP2A inhibitor, KYP-2047 did not have effect on lithium-induced GSK3b and Akt phosphorylation. Therefore, we conclude that PREP deletion or inhibition blocks the intracellular effects of lithium on GSK3b and Akt via PP2A activation.
dc.format.pagerange287
dc.format.pagerange296
dc.identifier.jour-issn1742-7835
dc.identifier.olddbid184829
dc.identifier.oldhandle10024/167923
dc.identifier.urihttps://www.utupub.fi/handle/11111/51724
dc.identifier.urnURN:NBN:fi-fe2021093048812
dc.language.isoen
dc.okm.affiliatedauthorMyöhänen, Timo
dc.okm.discipline3111 Biomedicineen_GB
dc.okm.discipline3111 Biolääketieteetfi_FI
dc.okm.internationalcopublicationinternational co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherWILEY
dc.publisher.countryUnited Statesen_GB
dc.publisher.countryYhdysvallat (USA)fi_FI
dc.publisher.country-codeUS
dc.relation.doi10.1111/bcpt.13632
dc.relation.ispartofjournalBasic and Clinical Pharmacology and Toxicology
dc.relation.issue4
dc.relation.volume129
dc.source.identifierhttps://www.utupub.fi/handle/10024/167923
dc.titleDeletion or inhibition of prolyl oligopeptidase blocks lithium-induced phosphorylation of GSK3b and Akt by activation of protein phosphatase 2A
dc.year.issued2021

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
bcpt.13632.pdf
Size:
1.32 MB
Format:
Adobe Portable Document Format
Description:
Publisher's pdf